Biotech company pushes development of hydrogel-based wound product

10/8/2013 | PharmaBiz.com (India)

Biotechnology company BioTime has begun pre-approval testing of a wound dressing based on cross-linked thiol-modified hyaluronan and thiol-modified gelatin. The product maintains a moist wound bed, and a biodegradable matrix serves as a scaffold for cellular infiltration and capillary growth. If approved, the product may provide a foundation for bioactive wound care products that deliver biological factors or cells.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ